MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention
ConclusionsIn real-life, in a personalized managed access program, erenumab shows a good effectiveness profile and an excellent tolerability in migraine prevention in our cohort of refractory patients.
Source: The Journal of Headache and Pain - Category: Neurology Source Type: research
More News: Brain | Chronic Pain | Constipation | Disability | Headache | Migraine | Neurology | Pain | Spain Health